Researchers identify how enzyme affects infertility and cancer progression
Researchers used preclinical models to identify how changes to the Dicer enzyme affect both infertility and cancer progression
The study identified a specific genetic sequence that, when activated, can change Dicer¡¯s role
Understanding Dicer modifications may help researchers discover new ways to combat its role infertility and cancer
Activation of a specific part of the Dicer enzyme can change its shape in a way that affects its critical...
Novel combination therapy yields high response rates in early-stage classical Hodgkin lymphoma
Phase 2 trial evaluated abbreviated chemotherapy?plus brentuximab vedotin and nivolumab
Combination?achieved complete response in&...
Imaging tool reveals novel insights into DNA replication stress response
Reversed DNA replication forks protect against stress to maintain genomic stability and serve as central components to cancer resistance, disease...
Novel tool more accurately predicts risk of Li-Fraumeni Syndrome
In a prospective validation study, researchers at Â鶹ӳ» MD Anderson Cancer Center demonstrated that a new mathematical model, called LFSPRO, was effective in supporting genetic counselor decision-making and more accurately predicted individuals at higher risk of Li-Fraumeni Syndrome (LFS), a hereditary condition that carries a higher risk of developing multiple cancers.
LFSPRO provided risk scores that significantly...
FLAG-based regimen delivers strong outcomes in subtype of acute myeloid leukemia
Highest reported five-year,?relapse-free survival?and overall survival?rates, especially with FLAG-GO??
<...
AACR: Novel approach prevents cancer progression, spares surgery for majority of patients with precancerous oral lesions
Precancerous oral lesions can progress to oral cancer and are typically ablated or surgically removed as a preventive measure
Direct injection...
AACR: New platform uses machine learning to predict responses in patients with lung cancer
Path-IO is a machine learning platform that incorporates pathology data to predict how patients with non-small cell lung cancer will respond...
AACR: Zedoresertib and lunresertib combination shows promising antitumor activity
Phase I trial provides early clinical proof-of-concept supporting the combination of zedoresertib and lunresertib in certain advanced solid...
AACR: Clinical trial presentations feature advances across cancer care
Early results for first-in-human and first-in-class therapies including an integrin inhibitor and a genetically engineered tumor infiltrating...
First-line targeted therapy shows antitumor activity in patients with advanced lung cancer
First-line?zongertinib?showed antitumor activity in?treatment-na?ve patients with advanced or metastatic?HER2-mutant ...
AACR: UT MD Anderson shares latest breakthroughs in cancer research
ABSTRACTS:?NG05, 1296, 1297, 1361, 1366, 2709, 3451, 4010, 4020, 4033, 4053, 6724, 6743, 6761, 6788, 6803
Researchers from The...
Researchers find new target to sensitize pancreatic tumors to immunotherapy
DPY30 acts as an epigenetic regulator to help pancreatic tumors maintain genomic stability
Targeting DPY30 triggers immune cell infiltration...
Study identifies strategy to overcome radiation therapy resistance in lung cancer
These results show how mitochondrial enzyme dihydroorotate dehydrogenase contributes to radiation therapy resistance
Researchers were able to...
Researchers identify blood-based biomarker for cancer risk in people with Lynch Syndrome
Lynch Syndrome (LS) is a hereditary condition involving mutations in DNA mismatch repair genes
Researchers sequenced T cell receptors in blood...
Radiation therapy improves outcomes for 'supermassive¡¯ bile duct tumors
Patient outcomes were significantly better?when treated with radiation therapy?plus?standard-of-care chemotherapy?
First-in-class radio-theranostic utilizes novel antibody developed at UT MD Anderson
Study details the development of a novel antibody that targets a specific type of B7-H3, a protein overexpressed in many cancers?